Type II

FDA Approves Once-Weekly GLP-1 Diabetes Treatment Regimen for T2DM

Dulaglutide is a member of the glucagon-like peptide (GLP-1) receptor agonist class, along with liraglutide, exenatide, and albiglutide. The US Food and Drug Administration (FDA) has approved dulaglutide (Trulicity) as a once a week injection for the treatment of adults with type 2 diabetes.

DiabetesHealth – Duodenum Resurfacing Procedure Improves Type 2 Diabetes Markers

A procedure designed to change how the body absorbs and processes glucose could help improve A1C numbers for those with type 2 diabetes, according to recent research.

WebMD – Obesity Isn’t Sole Cause of Type 2 Diabetes

Although the type 2 diabetes epidemic is commonly linked to being overweight or obese, excess weight isn’t the only factor driving the trend, new research suggests.

DiabetesInControl – Fibrates Can Reduce Cardiovascular Risk in Type 2’s

Patients with type 2 diabetes are at increased risk of cardiovascular disease. Fibrate may help decrease the risk of cardiovascular disease in women and could be an option for patients who cannot tolerate statins.

BattleDiabetes – Hormone-insulin combo more effective for TII than other therapies

A drug that mimics the action of a gut hormone combined with basal insulin is more effective at controlling blood sugar than other diabetes treatments, according to new research published in The Lancet.

DiabetesInControl – Diet and Physical Activity Reduce Inflammatory Markers in Type 2

Inflammation plays a major role in diabetes-associated cardiovascular disease (CVD). There is uncertainty whether diet and physical activity interventions can be successfully integrated into healthcare settings and reduce markers of inflammation and risk of CVD in patients with type 2 diabetes (T2D).

Diabetes Self-Management – Pistachios Offer Protection for People With TII Diabetes

Research has indicated that eating pistachios along with a high-glycemic meal may help lower after-meal blood sugar response, particularly in people with metabolic syndrome. Now, a small new study from Penn State University suggests that these nuts may also improve heart health in people who have Type 2 by reducing the body’s cardiovascular responses to […]

DiabetesInControl – Diabetic Neuropathy Improved with Vegan Diet

Diabetic peripheral neuropathy, which occurs in about half of all patients with type 2 diabetes, is underdiagnosed, and this is partly because physicians aren”t able to offer anything to treat the underlying cause of this condition, and the current treatments provided to these patients only treat the pain.

Battle Diabetes – Work-related stress can raise diabetes risk by 45 percent

Individuals who experience high levels of workplace stress are about 45 percent more likely to develop type 2 diabetes than those who have less taxing jobs, according to research published in the journal Psychosomatic Medicine.

MedXpress – Very low carbohydrate diet beneficial for obese with T2DM

For obese adults with type 2 diabetes mellitus (T2DM), a very low carbohydrate diet is associated with greater improvements in glycemic control and cardiovascular risk markers than an energy-matched high unrefined carbohydrate diet, according to a study published online July 28 in Diabetes Care.

Low-carb Diet Recommended for Type 1 and 2 Diabetes Patients

Low-carbohydrate diets should be the first line of attack for treatment of type 2 diabetes, and should be used in conjunction with insulin in those with type 1 diabetes.

MNT – Discovery of glucose sensor in brain may lead to new diabetes treatments

There is an enzyme in the brain that plays a key role in sensing and controlling levels of glucose in the blood. The underlying mechanism that it triggers appears to link to both type 1 and type 2 diabetes, according to US researchers, who suggest the discovery could lead to new treatments for diabetes.

Insulin Nation – Insulin Cocktails, Mouse Cures, Group Appointments

A group of European health regulators have recommended the approval of a drug treatment that combines long-lasting insulin with a drug that promotes insulin secretion. Also in the news: A new study is examining whether a common gout medication can help prevent kidney disease in people with Type 1 diabetes.

MedicalXpress – Pesticide DDT linked to slow metabolism, obesity and diabetes

Exposure of pregnant mice to the pesticide DDT is linked to an increased risk of obesity, diabetes, high cholesterol and related conditions in female offspring later in life, according to a study led by the University of California, Davis.

BBC – ‘Tape measure test’ call on type 2 diabetes

People are being urged to whip out the tape measure to assess their risk of developing type 2 diabetes. Public Health England said there was a “very high risk” of diabetes with waistlines over 40in (102cm) in men or 35in (88cm) in women.

BattleDiabetes – Does your job put you at risk for diabetes?

If your job consists of shift work, especially rotating shifts, you may have a much higher risk of developing diabetes, according to a study published in Occupational & Environmental Medicine.

Health.com – 15 Exercise Tips for People With Type 2 Diabetes

Exercise is safe—and highly recommended—for most people with type 2 diabetes, including those with complications. Along with diet and medication, exercise will help you lower blood sugar and lose weight.

DiabetesInControl – Statins Linked to New Onset TII Diabetes Risk

In a retrospective cohort study, Giovanni Corrao and colleagues from the University of Milano-Bicocca, Italy, evaluated 115,709 individuals who were recently diagnosed with diabetes and treated with statins during the time period of 2003-2004 and followed prospectively until 2010.

US News – Study Links Shift Work to Risk for Type 2 Diabetes

Shift workers, especially men, may be at higher risk for type 2 diabetes compared to people not on such schedules, a new study suggests. Also at special risk are shift workers who don’t work on a set schedule, with shifts moving around at various times of the day.

DiabetesInControl – Are Insulin Pumps a Better Choice than Multiple Insulins for Type 2’s?

Patients in the study all had uncontrolled type 2 diabetes and were between the ages 30 to 75. Results showed that after 6 months, patients with an insulin pump had a significantly greater decrease in their average blood glucose levels compared to the patients who had multiple injections per day.